share print

EXECUTIVE LEADERSHIP TEAM

Together, our nine members of the Executive Leadership Team are responsible for worldwide operations. This experienced management team has a proven track record and a core focus on customer excellence and financial performance.
Since 2017, David Wright, has been HRA Pharma's Chief Executive Officer and President of the Executive Leadership Team. Together, our members inspire HRA Pharma teams to dream, dare, share.

David Wright

David Wright

Chief Executive Officer

Role At HRA Pharma: David Wright  is HRA Pharma's Chief Executive Officer and President of the Executive Leadership Team.
 

Professional BackgroundDavid joined HRA Pharma in 2017. Former Senior Vice President Global OTC operations of Boehringer-Ingelheim Consumer Healthcare, David Wright has 25 years of professional experience in the field of consumer healthcare. He started his career at Boots Consumer Healthcare prior to joining Sandoz (formerly Novartis) in 1992 as Sales Director. In 1997, David Wright took over as UK Director of Boehringer-Ingelheim Consumer Healthcare, before becoming Global Marketing Director in 2004, and Senior Vice President Global OTC operations in 2010. In this capacity, he had a global responsibility over Boehringer Ingelheim’s activities in the OTC space, with sales in 63 countries (1.8 billion EUR in turnover).

 

Key knowledge:

David Wright

David Wright

UNITED KINGDOM

Chief Executive Officer

David Wright is HRA Pharma's Chief Executive Officer and President of the Executive Leadership Team. David joined HRA Pharma in 2017. Former Senior Vice President Global OTC operations of Boehringer-Ingelheim Consumer Healthcare, David Wright has 25 years of professional experience in the field of consumer healthcare. He started his career at Boots Consumer Healthcare prior to joining Sandoz (formerly Novartis) in 1992 as Sales Director. In 1997, David Wright took over as UK Director of Boehringer-Ingelheim Consumer Healthcare, before becoming Global Marketing Director in 2004, and Senior Vice President Global OTC operations in 2010. In this capacity, he had a global responsibility over Boehringer Ingelheim’s activities in the OTC space, with sales in 63 countries (1.8 billion EUR in turnover).

Geoff Allan

Geoff Allan

Chief Financial Officer

Role At HRA Pharma: Geoff Allan joined HRA Pharma as Chief Financial Officer and member of the Executive Leadership Team in November 2011.


Professional Background
: Prior to this, Geoff served for five years as CFO of Kewego, a leading International provider of internet based video broadcasting solutions. Geoff was responsible for all financial, legal and administrative aspects of the business and participated actively in making Kewego the first profitable company in its sector, in all fund raising and investor relations activities as well as in the sale negotiations.
Before to this, Geoff occupied various senior financial management positions in different service and technology businesses, in particular as CFO of the 3i and Edmond de Rothschild backed Franco-US firm, eDevice, and prior to that working directly for leading French entrepreneurs such as André Rousselet, Founder of Canal +.


Education
: Geoff began his career as a financial analyst for an independent stock market listed investment firm, prior to joining the mergers and acquisitions department of The Chase Manhattan Bank in Paris. Geoff has worked on many fund raising and mergers and acquisitions transactions, involving both private and public operations.
Geoff holds honours degrees in Law from King's College, University of London and from the University of Paris I, Pantheon – Sorbonne.

Key knowledge:

Geoff Allan

Geoff Allan

UNITED KINGDOM

Chief Financial Officer

Geoff Allan has enjoyed a diverse financial career, occupying senior management positions across a range of industries, including a five-year period as CFO for Kewego, an international provider of internet-based video broadcasting solutions. While Geoff was CFO at Kewego, the company became the first profitable company in its sector. He joined HRA Pharma as CFO in 2011.

Anne-Laure Astecker

Anne-Laure Astecker

Director, Regulatory & Compliance

Role At HRA Pharma: Anne-Laure Astecker has been Regulatory and Compliance Director of HRA Pharma since October 2013. She leads the development and implementation of the global regulatory strategies and designs and implements corporate compliance programs. She is a member of the Executive Leadership Team of the company.
 

Professional Background: Anne-Laure Astecker joined HRA Pharma in 2008 as regulatory officer and then moved to the position of head of regulatory affairs. Before joining HRA Pharma, Ms. Astecker was in charge of a Development Registration Center in Austria. Prior to that, she aquired experience in regulatory activities within Aventis Pharma in Paris France and GlaxoSmithKline in the UK.
 

Education: Ms. Astecker graduated in 2001 with a pharmacy degree from University of Rennes, France and with a Master of international drug development and registration from University of Châtenay-Malabry, Paris XI France.

Key knowledge:

Anne-Laure Astecker

Anne-Laure Astecker

FRANCE

Director, Regulatory & Compliance

Anne-Laure Astecker has been Regulatory and Compliance Director of HRA Pharma since October 2013. She leads the development and implementation of the global regulatory strategies and designs and implements corporate compliance programs. Prior to joining our company, Anne-Laure was in charge of a Development Registration Center in Austria. She has also worked at Aventis Pharma in Paris, France, and GlaxoSmithKline in the UK.

Pascale Borensztein

Pascale Borensztein

Director Of Research And Development

Role At HRA Pharma: Pascale Borensztein has been Director of Research and Development at HRA Pharma since January 2016. She is a member of the Executive Leadership Team of HRA Pharma.

 

Professional Background: Before joining the company, Ms. Borensztein was International Project Director for Servier, a position she held for six years. Previously, she spent about 15 years as Head of Research and then Director of Research within the French National Institute for Health and Medical Research (INSERM). Pascale Borensztein has extensive experience of pharmaceutical R&D in all phases, from early discovery through to clinical trials and has experience of leading clinical development in several major disease areas.

 


Education: Pascale Borensztein received an M.D. from the Denis Diderot University and did her residency in Paris. She is a board certified endocrinologist with a qualification in renal physiology. She has an extensive mentoring and teaching experience guiding multiple sections of undergraduate, graduate and post-graduate students.

 

  

 

 

 

Key knowledge:

Pascale Borensztein

Pascale Borensztein

FRANCE

Director Of Research And Development

Pascale Borensztein has been Director of Research and Development at HRA Pharma since January 2016. She is a board certified endocrinologist with an extensive experience of pharmaceutical R&D in all phases, from early discovery through to clinical trials and has experience of leading clinical development in several major disease areas.

Martyn Hilton

Martyn Hilton

Director, Global Commercial

Role At HRA Pharma: Martyn Hilton is the company’s Global Commercial Director and member of the Executive Leadership Team.
 

Professional Background: Martyn Hilton joined HRA Pharma in 2017. Former Global Head of Trade and Shopper at Boehringer-Ingelheim Consumer Healthcare, he is a highly accomplished sales professional with almost 20 years of professional experience working in Consumer Health and FMCG companies across Europe, North America, Latin America, Middle East and Asia Pacific. He started his career in marketing at Boots the Chemists, then held senior customer management positions for Boots Healthcare International. In 2006 he joined Reckitt Benckiser, a company within which he held successive positions, first as Global Sales Development Manager then as Global Trade Marketing Director (Healthcare), Global Customer Marketing Director (Healthcare and Wellbeing) and finally Sales Director at Reckitt Benckiser Thailand.


Education
: Martyn holds an honours BA degree from the Nottingham Trent University.

Key knowledge:

Martyn Hilton

Martyn Hilton

UNITED KINGDOM

Director, Global Commercial

Martyn Hilton joined HRA Pharma in 2017. Former Global Head of Trade and Shopper at Boehringer-Ingelheim Consumer Healthcare, he is a highly accomplished sales professional with almost 20 years of professional experience working in Consumer Health and FMCG companies across Europe, North America, Latin America, Middle East and Asia Pacific. He started his career in marketing at Boots the Chemists, then held senior customer management positions for Boots Healthcare International. In 2006 he joined Reckitt Benckiser, a company within which he held successive positions, first as Global Sales Development Manager then as Global Trade Marketing Director (Healthcare), Global Customer Marketing Director (Healthcare and Wellbeing) and finally Sales Director at Reckitt Benckiser Thailand. Martyn holds an honours BA degree from the Nottingham Trent University.

Sophie Lacourrege

Sophie Lacourrege

Director, Human Resources

Role at HRA Pharma: Sophie Lacourrege is the company’s Director of Human Resources and member of the Executive Leadership Team.  

Professional Background: Sophie Lacourrege has joined the company in 2017. She is a senior manager operating in international environments with 20 years of experience in people and organizations’ development, change management, employment relations and project management. She joined HRA Pharma from the French subsidiary of Celgene where she was Human Resources Director, a role she has held for 9 years. 
 

Education: Sophie holds a diploma of Institut d’Etudes Politiques from Science Pô Bordeaux, a Master's degree of Labour Law from University of Bordeaux I, and a postgraduate degree in “Human Resources Management & Employement Relations” from the University of Social Sciences in Toulouse.

Key knowledge:

Sophie Lacourrege

Sophie Lacourrege

FRANCE

Director, Human Resources

Sophie Lacourrege has joined the company in 2017. She leads Human Resources at HRA Pharma. Sophie is a senior manager operating in international environments with 20 years of experience in people and organizations’ development, change management, employment relations and project management. She joined HRA Pharma from the French subsidiary of Celgene where she spent 9 years as Human Resources Director. Sophie holds a diploma of Institut d’Etudes Politiques from Sciences Pô Bordeaux, a Master’s degree of Labour Law from University of Bordeaux I, and a postgraduate degree in “Human Resources Management & Employement Relations” from the University of Social Sciences in Toulouse.

Emmanuel Sensale

Emmanuel Sensale

Director, Supply Chain

Role At HRA PharmaEmmanuel Sensale has been Supply Chain Director of HRA Pharma since December 2014. In this role, he is responsible for optimizing the performance of the company’s global supply chain while providing strategic industrial orientations. He is a member of the Executive Leadership Team of HRA Pharma.
 

Professional BackgroundEmmanuel joined HRA Pharma from IBA Molecular Tracers, France where he first managed the company’s European operations then eventually moved to supply chain division, which he led until November 2014. Prior to that, Emmanuel served 12 years at Pfizer where he assumed positions of increasing responsibility in quality, production, supply chain and insourcing & outsourcing departments.

Education: Emmanuel holds a PhD in Industrial Maintenance and Information Technology from Valenciennes University. In 2001, he received Supply Chain Expert diploma from ISERPA Angers; then in 2004, he completed Production and Inventory Management Certification at CPIM-APICS.

 

Key knowledge:

Emmanuel Sensale

Emmanuel Sensale

FRANCE

Director, Supply Chain

Emmanuel Sensale has been Supply Chain Director of HRA Pharma since December 2014. He is a senior supply chain professional whose career has seen extensive capability development across the key functions of logistics and supply chain leadership in healthcare industry.

Frédérique Welgryn

Frédérique Welgryn

Chief Operating Officer

Role At HRA Pharma: Frédérique Welgryn has been Chief Operating Officer since 2016. In this role, she is responsible for overseeing ongoing business operations within the company and creating operations strategy and policies. She is a member of the Executive Leadership Team of HRA Pharma.
 

Professional Background: Frédérique Welgryn was HRA Pharma's Women's Health Therapeutic Domain Director from 2012 to 2016.  In that role, she was responsible for providing commercial leadership and maximizing the value of the company's Women's Health activities. Ms. Welgryn began her career with HRA Pharma in 2010 as the Operations Director of the company's French subsidiary. Prior to joining HRA Pharma, she held various leadership positions as Marketing & Sales Director and Business Units Manager with large pharmaceutical companies such as Roche, Sanofi and AstraZeneca. She also served as managing consultant for the Strategy and Transformation Division of CAP Gemini Ernst & Young.


Education
: Frédérique graduated with a Bachelor of Science in Pharmacy and a master in Pharmaceutical Marketing and Management from Paris V University (France). She completed her MSc in Management at HEC Paris Business School (Ecole des hautes études commerciales de Paris, France).

Key knowledge:

Frédérique Welgryn

Frédérique Welgryn

FRANCE

Chief Operating Officer

Frédérique Welgryn is HRA Pharma's Chief Operating Officer. Prior to this, she was Global Director for Women’s Health Therapeutic Domain. Previously, she worked for large pharmaceutical companies such as Roche, Sanofi and AstraZeneca. Frédérique also served as a managing consultant in the Strategy and Transformation Division of CAP Gemini Ernst & Young.

closeyou are leaving hra pharma
You are now leaving www.hra-pharma.com and being redirected to an external website which might not be under control of HRA Pharma.
do you want to proceed ?